These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22760497)
1. CD24 controls Src/STAT3 activity in human tumors. Bretz NP; Salnikov AV; Perne C; Keller S; Wang X; Mierke CT; Fogel M; Erbe-Hofmann N; Schlange T; Moldenhauer G; Altevogt P Cell Mol Life Sci; 2012 Nov; 69(22):3863-79. PubMed ID: 22760497 [TBL] [Abstract][Full Text] [Related]
2. Antibody-based targeting of CD24 enhances antitumor effect of cetuximab via attenuating phosphorylation of Src/STAT3. Chen Z; Wang T; Tu X; Xie W; He H; Wang M; Zhang J Biomed Pharmacother; 2017 Jun; 90():427-436. PubMed ID: 28391164 [TBL] [Abstract][Full Text] [Related]
3. CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion. Baumann P; Thiele W; Cremers N; Muppala S; Krachulec J; Diefenbacher M; Kassel O; Mudduluru G; Allgayer H; Frame M; Sleeman JP Cell Mol Life Sci; 2012 Feb; 69(3):435-48. PubMed ID: 21710320 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells. Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586 [TBL] [Abstract][Full Text] [Related]
6. Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24. Yoshida M; Zhao L; Grigoryan G; Shim H; He P; Yun CC Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G586-98. PubMed ID: 26867566 [TBL] [Abstract][Full Text] [Related]
7. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas. Salnikov AV; Bretz NP; Perne C; Hazin J; Keller S; Fogel M; Herr I; Schlange T; Moldenhauer G; Altevogt P Br J Cancer; 2013 Apr; 108(7):1449-59. PubMed ID: 23511563 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295 [TBL] [Abstract][Full Text] [Related]
9. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation. Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216 [TBL] [Abstract][Full Text] [Related]
10. Src and focal adhesion kinase mediate mechanical strain-induced proliferation and ERK1/2 phosphorylation in human H441 pulmonary epithelial cells. Chaturvedi LS; Marsh HM; Basson MD Am J Physiol Cell Physiol; 2007 May; 292(5):C1701-13. PubMed ID: 17215324 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells. Pathania D; Kuang Y; Sechi M; Neamati N Br J Pharmacol; 2015 Jan; 172(1):50-63. PubMed ID: 25047070 [TBL] [Abstract][Full Text] [Related]
13. GDNF induces RET-SRC-HER2-dependent growth in trastuzumab-sensitive but SRC-independent growth in resistant breast tumor cells. Gardaneh M; Shojaei S; Kaviani A; Behnam B Breast Cancer Res Treat; 2017 Apr; 162(2):231-241. PubMed ID: 28116540 [TBL] [Abstract][Full Text] [Related]
14. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. Marotta LL; Almendro V; Marusyk A; Shipitsin M; Schemme J; Walker SR; Bloushtain-Qimron N; Kim JJ; Choudhury SA; Maruyama R; Wu Z; Gönen M; Mulvey LA; Bessarabova MO; Huh SJ; Silver SJ; Kim SY; Park SY; Lee HE; Anderson KS; Richardson AL; Nikolskaya T; Nikolsky Y; Liu XS; Root DE; Hahn WC; Frank DA; Polyak K J Clin Invest; 2011 Jul; 121(7):2723-35. PubMed ID: 21633165 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer. Byers LA; Sen B; Saigal B; Diao L; Wang J; Nanjundan M; Cascone T; Mills GB; Heymach JV; Johnson FM Clin Cancer Res; 2009 Nov; 15(22):6852-61. PubMed ID: 19861436 [TBL] [Abstract][Full Text] [Related]
16. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells. Laird AD; Li G; Moss KG; Blake RA; Broome MA; Cherrington JM; Mendel DB Mol Cancer Ther; 2003 May; 2(5):461-9. PubMed ID: 12748308 [TBL] [Abstract][Full Text] [Related]
17. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity. Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220 [TBL] [Abstract][Full Text] [Related]
18. SNARE-mediated membrane traffic is required for focal adhesion kinase signaling and Src-regulated focal adhesion turnover. Skalski M; Sharma N; Williams K; Kruspe A; Coppolino MG Biochim Biophys Acta; 2011 Jan; 1813(1):148-58. PubMed ID: 20888376 [TBL] [Abstract][Full Text] [Related]
19. Activation of Src and Src-associated signaling pathways in relation to hypoxia in human cancer xenograft models. Pham NA; Magalhaes JM; Do T; Schwock J; Dhani N; Cao PJ; Hill RP; Hedley DW Int J Cancer; 2009 Jan; 124(2):280-6. PubMed ID: 18924149 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-3064-5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway. Zhang P; Ha M; Li L; Huang X; Liu C FASEB J; 2020 Jan; 34(1):66-81. PubMed ID: 31914639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]